Latest News by Industry
NEW YORK (AP) — NEW YORK (AP) — Immunic, Inc. (IMUX) on Thursday reported a loss of $21.4 million in its second quarter.
On a per-share basis, the New York-based company said it had a loss of 21 cents.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMUX at https://www.zacks.com/ap/IMUX